Substituted hydroxyapatites for bone regeneration: A review of current trends

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 105, Issue 5, 2017, Pages 1285-1299

  Ratnayake, Jithendra T B ^a   Mucalo, Michael ^b   Dias, George J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF WAIKATO   (New Zealand)

Author keywords

bone and bone grafts; calcium phosphates; hydroxyapatite; ionic substitutions

Indexed keywords

BONE; CALCIUM; CALCIUM CARBONATE; CALCIUM PHOSPHATE; FLUORINE; FRACTURE MECHANICS; FRACTURE TOUGHNESS; HYDROXYAPATITE; MEDICAL APPLICATIONS; TISSUE REGENERATION;

BIOLOGICAL PROPERTIES; BIOMEDICAL APPLICATIONS; BONE GRAFT; BONE REGENERATION; CALCIUM DEFICIENTS; IONIC SUBSTITUTIONS; OSSEOINTEGRATION; SUBSTITUTED HYDROXYAPATITES;

CRYSTAL STRUCTURE;

BARIUM; BIOCERAMICS; BISMUTH; CARBONIC ACID; CERIUM; CHLORINE; CITRIC ACID; COBALT; COPPER; EUROPIUM; FLUORIDE; GALLIUM; HYDROXYAPATITE; INDIUM; IRON; LANTHANUM; MAGNESIUM; MANGANESE; NIOBATE; NIOBIUM; POTASSIUM; SILICATE; SILICON; SILVER; SODIUM; STRONTIUM; TANTALATE; TANTALUM; UNCLASSIFIED DRUG; YTTRIUM; ZINC;

BIOCOMPATIBILITY; BONE CELL; BONE CONDUCTION; BONE DEFECT; BONE MINERAL; BONE REGENERATION; BONE REMODELING; BONE RESECTION; CRYSTAL STRUCTURE; DISSOLUTION; HUMAN; OSSEOINTEGRATION; OSSIFICATION; REVIEW; STOICHIOMETRY; X RAY DIFFRACTION; ANIMAL; BONE PROSTHESIS; CHEMISTRY; DRUG EFFECTS; THERAPEUTIC USE;

ANIMALS; BONE REGENERATION; BONE SUBSTITUTES; DURAPATITE; HUMANS; OSSEOINTEGRATION;

EID: 84961266880     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.33651     Document Type: Review

References (171)

1. Saladin KS, Porth CM. Anatomy & physiology. New York: McGraw-Hill; 1998.
2. Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: An update. Injury 2005;36(Suppl3):S20–27.
3. Summers BN, Eisenstein SM. Donor site pain from the ilium. A complication of lumbar spine fusion. J Bone Joint Surg Br 1989;71:677–680.
4. Nandi SK, Roy S, Mukherjee P, Kundu B, De DK, Basu D. Orthopaedic applications of bone graft & graft substitutes: A review. Indian J Med Res 2010;132:15–30.
5. Akram M, Ahmed R, Shakir I, Ibrahim WAW, Hussain R. Extracting hydroxyapatite and its precursors from natural resources. J Mater Sci 2014;49:1461–1475.
6. Gibson IR, Best SM, Bonfield W. Chemical characterization of silicon-substituted hydroxyapatite. J Biomed Mater Res 1999;44:422–428.
7. Elliott JC. Structure and chemistry of the apatites and other calcium orthophosphates. Stud Org Chem 1994;18:63–103.
8. LeGeros RZ. Calcium phosphates in oral biology and medicine. Monogr Oral Sci 1990;15:1–201.
9. Shepherd JH, Shepherd DV, Best SM. Substituted hydroxyapatites for bone repair. J Mater Sci Mater Med 2012;23:2335–2347.
10. Worth A, Mucalo M, Horne G, Bruce W, Burbidge H. The evaluation of processed cancellous bovine bone as a bone graft substitute. Clin Oral Implants Res 2005;16:379–386.
11. Knowles JC, Talal S, Santos JD. Sintering effects in a glass reinforced hydroxyapatite. Biomaterials 1996;17:1437–1442.
12. Kim HW, Li LH, Koh YH, Knowles JC, Kim HE. Sol–gel preparation and properties of fluoride-substituted hydroxyapatite powders. J Am Ceram Soc 2004;87:1939–1944.
13. Saranya K, Kowshik M, Ramanan SR. Synthesis of hydroxyapatite nanopowders by sol-gel emulsion technique. Bull Mater Sci 2011;34:1749–1753.
14. Shepherd D, Best SM. Production of zinc substituted hydroxyapatite using various precipitation routes. Biomed Mater 2013;8:025003.
15. Fathi MH, Hanifi A, Mortazavi V. Preparation and bioactivity evaluation of bone-like hydroxyapatite nanopowder. J Mater Process Technol 2008;202:536–542.
16. Barakat NAM, Khil MS, Omran AM, Sheikh FA, Kim HY. Extraction of pure natural hydroxyapatite from the bovine bones bio waste by three different methods. J Mater Process Technol 2009;209:3408–3415.
17. Hayashi K, Inadome T, Mashima T, Sugioka Y. Comparison of bone-implant interface shear strength of solid hydroxyapatite and hydroxyapatite-coated titanium implants. J Biomed Mater Res 1993;27:557–563.
18. Søballe K, Hansen ES, B-Rasmussen H, Jørgensen PH, Bünger C. Tissue ingrowth into titanium and hydroxyapatite-coated implants during stable and unstable mechanical conditions. J Orthop Res 1992;10:285–299.
19. Chatterjea A, Meijer G, van Blitterswijk C, de Boer J. Clinical application of human mesenchymal stromal cells for bone tissue engineering. Stem Cells Int 2010;2010:215625.
20. Bagambisa FB, Joos U. Preliminary studies on the phenomenological behaviour of osteoblasts cultured on hydroxyapatite ceramics. Biomaterials 1990;11:50–56.
21. Best S, Sim B, Kayser M, Downes S. The dependence of osteoblastic response on variations in the chemical composition and physical properties of hydroxyapatite. J Mater Sci Mater Med 1997;8:97–103.
22. Gomi K, Lowenberg B, Shapiro G, Davies JE. Resorption of sintered synthetic hydroxyapatite by osteoclasts in vitro. Biomaterials 1993;14:91–96.
23. Monchau F, Lefevre A, Descamps M, Belquin-myrdycz A, Laffargue P, Hildebrand HF. In vitro studies of human and rat osteoclast activity on hydroxyapatite, beta-tricalcium phosphate, calcium carbonate. Biomol Eng 2002;19:143–152.
24. Khairoun I, Boltong MG, Driessens FC, Planell JA. Effect of calcium carbonate on clinical compliance of apatitic calcium phosphate bone cement. J Biomed Mater Res 1997;38:356–60.
25. Lee YK, Lim BS, Kim CW. Mechanical properties of calcium phosphate based dental filling and regeneration materials. J Oral Rehabil 2003;30:418–425.
26. Kannan S, Ventura JMG, Lemos AF, Barba A, Ferreira JMF. Effect of sodium addition on the preparation of hydroxyapatites and biphasic ceramics. Ceram Int 2008;34:7–13.
27. Matsunaga K, Murata H. Formation Energies of Substitutional Sodium and Potassium in Hydroxyapatite. Mater Trans 2009;50:1041–1045.
28. Sang Cho J, Um SH, Su Yoo D, Chung YC, Hye Chung S, Lee JC, Rhee SH. Enhanced osteoconductivity of sodium-substituted hydroxyapatite by system instability. J Biomed Mater Res B Appl Biomater 2014;102:1046–1062.
29. Wiesmann HP, Plate U, Zierold K, Hohling HJ. Potassium is involved in apatite biomineralization. J Dent Res 1998;77:1654–1657.
30. Kannan S, Ventura JMG, Ferreira JMF. Synthesis and thermal stability of potassium substituted hydroxyapatites and hydroxyapatite/β-tricalciumphosphate mixtures. Ceram Int 2007;33:1489–1494.
31. Nordstrom EG, Karlsson KH. Chemical characterization of a potassium hydroxyapatite prepared by soaking in potassium chloride and carbonate solutions. Biomed Mater Eng 1992;2:185–189.
32. Ewald A, Hosel D, Patel S, Grover LM, Barralet JE, Gbureck U. Silver-doped calcium phosphate cements with antimicrobial activity. Acta Biomater 2011;7:4064–4070.
33. Nirmala R, Sheikh FA, Kanjwal MA, Lee JH, Park SJ, Navamathavan R, Kim HY. Synthesis and characterization of bovine femur bone hydroxyapatite containing silver nanoparticles for the biomedical applications. J Nanoparticle Res 2011;13:1917–1927.
34. Liu XM, Mou YA, Wu SL, Man HC. Synthesis of silver-incorporated hydroxyapatite nanocomposites for antimicrobial implant coatings. Appl Surf Sci 2013;273:748–757.
35. Torres N, Oh S, Appleford M, Dean DD, Jorgensen JH, Ong JL, Agrawal CM, Mani G. Stability of antibacterial self-assembled monolayers on hydroxyapatite. Acta Biomater 2010;6:3242–3255.
36. Chen YK, Zheng XB, Xie YT, Ji H, Ding CX, Li HW, Dai KR. Silver release from silver-containing hydroxyapatite coatings. Surf Coat Technol 2010;205:1892–1896.
37. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 2009;27:76–83.
38. Lim PN, Teo EY, Ho B, Tay BY, Thian ES. Effect of silver content on the antibacterial and bioactive properties of silver-substituted hydroxyapatite. J Biomed Mater Res A 2013;101:2456–2464.
39. Kim TN, Feng QL, Kim JO, Wu J, Wang H, Chen GC, Cui FZ. Antimicrobial effects of metal ions (Ag+, Cu2+, Zn2+) in hydroxyapatite. J Mater Sci Mater Med 1998;9:129–134.
40. Díaz M, Barba F, Miranda M, Guitián F, Torrecillas R, Moya JS. Synthesis and antimicrobial activity of a silver-hydroxyapatite nanocomposite. J Nanomater 2009; 2009:14.
41. Ren F, Leng Y, Xin R, Ge X. Synthesis, characterization and ab initio simulation of magnesium-substituted hydroxyapatite. Acta Biomater 2010;6:2787–2796.
42. Landi E, Logroscino G, Proietti L, Tampieri A, Sandri M, Sprio S. Biomimetic Mg-substituted hydroxyapatite: From synthesis to in vivo behaviour. J Mater Sci Mater Med 2008;19:239–247.
43. Rude RK, Singer FR, Gruber HE. Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr 2009;28:131–141.
44. Bigi A, Foresti E, Gregorini R, Ripamonti A, Roveri N, Shah JS. The role of magnesium on the structure of biological apatites. Calcif Tissue Int 1992;50:439–444.
45. Tampieri A, Celotti G, Landi E, Sandri M. Magnesium doped hydroxyapatite: Synthesis and characterization. Euro Ceram 2004;264–268:2051-2054.
46. Sprio S, Pezzotti G, Celotti G, Landi E, Tampieri A. Raman and cathodoluminescence spectroscopies of magnesium-substituted hydroxyapatite powders. J Mater Res 2005;20:1009–1016.
47. Laurencin D, Almora-Barrios N, de Leeuw NH, Gervais C, Bonhomme C, Mauri F, Chrzanowski W, Knowles JC, Newport RJ, Wong A, Gan Z, Smith ME. Magnesium incorporation into hydroxyapatite. Biomaterials 2011;32:1826–1837.
48. Liu YT, Kung KC, Lee TM, Lui TS. Enhancing biological properties of porous coatings through the incorporation of manganese. J Alloys Compd 2013;581:459–467.
49. Pabbruwe MB, Standard OC, Sorrell CC, Howlett CR. Bone formation within alumina tubes: effect of calcium, manganese, and chromium dopants. Biomaterials 2004;25:4901–4910.
50. Miola M, Brovarone CV, Maina G, Rossi F, Bergandi L, Ghigo D, Saracino S, Maggiora M, Canuto RA, Muzio G, et al. In vitro study of manganese-doped bioactive glasses for bone regeneration. Mater Sci Eng C Mater Biol Appl 2014;38:107-118.
51. Bracci B, Torricelli P, Panzavolta S, Boanini E, Giardino R, Bigi A. Effect of Mg(2+), Sr(2+), and Mn(2+) on the chemico-physical and in vitro biological properties of calcium phosphate biomimetic coatings. J Inorg Biochem 2009;103:1666–1674.
52. Bigi A, Boanini E, Capuccini C, Gazzano M. Strontium-substituted hydroxyapatite nanocrystals. Inorg Chim Acta 2007;360:1009–1016.
53. Gerstenfeld S, Hinojosa L, Serrano Arias M, Menendez Rodriguez P, Fernandez Martin JL, Marchante JM, Garcia Alonso JI, Sanz-Medel A, Cannata Andia JB. Effect of strontium on bone metabolism in hemodialysis patients. Nefrologia 2003;23(Suppl):52–56.
54. Ravi ND, Balu R, Kumar TSS. Strontium-Substituted Calcium Deficient Hydroxyapatite Nanoparticles: Synthesis, Characterization, and Antibacterial Properties. J Am Ceram Soc 2012;95:2700–2708.
55. Li ZY, Lam WM, Yang C, Xu B, Ni GX, Abbah SA, Cheung KMC, Luk KDK, Lu WW. Chemical composition, crystal size and lattice structural changes after incorporation of strontium into biomimetic apatite. Biomaterials 2007;28:1452–1460.
56. Curran DJ, Fleming TJ, Towler MR, Hampshire S. Mechanical parameters of strontium doped hydroxyapatite sintered using microwave and conventional methods. J Mech Behav Biomed Mater 2011;4:2063–2073.
57. Kishi S, Yamaguchi M. Inhibitory effect of zinc compounds on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol 1994;48:1225–1230.
58. Ren F, Xin R, Ge X, Leng Y. Characterization and structural analysis of zinc-substituted hydroxyapatites. Acta Biomater 2009;5:3141–3149.
59. Peretz A, Papadopoulos T, Willems D, Hotimsky A, Michiels N, Siderova V, Bergmann P, Neve J. Zinc supplementation increases bone alkaline phosphatase in healthy men. J Trace Elem Med Biol 2001;15:175–178.
60. Chappell H, Shepherd D, Best S. Zinc substituted hydroxyapatite–a comparison of modelling and experimental data. Key Engineering Materials 2009;396:729–732.
61. Kishi S, Yamaguchi M. Inhibitory effect of zinc compounds on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol 1994;48:1225–1230.
62. Ma X, Ellis DE. Initial stages of hydration and Zn substitution/occupation on hydroxyapatite (0001) surfaces. Biomaterials 2008;29:257–265.
63. Miyaji F, Kono Y, Suyama Y. Formation and structure of zinc-substituted calcium hydroxyapatite. Mater Res Bull 2005;40:209–220.
64. Sogo Y, Ito A, Fukasawa K, Sakurai T, Ichinose N. Zinc containing hydroxyapatite ceramics to promote osteoblastic cell activity. Mater Sci Technol 2004;20:1079–1083.
65. Ito A, Ojima K, Naito H, Ichinose N, Tateishi T. Preparation, solubility, and cytocompatibility of zinc-releasing calcium phosphate ceramics. J Biomed Mater Res 2000;50:178–183.
66. Webster TJ, Ergun C, Doremus RH, Bizios R. Hydroxylapatite with substituted magnesium, zinc, cadmium, and yttrium. II. Mechanisms of osteoblast adhesion. J Biomed Mater Res 2002;59:312–317.
67. Velard F, Laurent-Maquin D, Braux J, Guillaume C, Bouthors S, Jallot E, Nedelec JM, Belaaouaj A, Laquerriere P. The effect of zinc on hydroxyapatite-mediated activation of human polymorphonuclear neutrophils and bone implant-associated acute inflammation. Biomaterials 2010;31:2001–2009.
68. Stanić V, Dimitrijević S, Antić-Stanković J, Mitrić M, Jokić B, Plećaš IB, Raičević S. Synthesis, characterization and antimicrobial activity of copper and zinc-doped hydroxyapatite nanopowders. Appl Surf Sci 2010;256:6083–6089.
69. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005;26:3995–4021.
70. Tran N, Webster TJ. Increased osteoblast functions in the presence of hydroxyapatite-coated iron oxide nanoparticles. Acta Biomater 2011;7:1298–1306.
71. Kramer ER, Morey AM, Staruch M, Suib SL, Jain M, Budnick JI, Wei M. Synthesis and characterization of iron-substituted hydroxyapatite via a simple ion-exchange procedure. J Mater Sci 2013;48:665–673.
72. Pon-On W, Meejoo S, Tang IM. Incorporation of iron into nano hydroxyapatite particles synthesized by the microwave process. Int J Nanosci 2007;6:9–16.
73. Johnson CH, VanTassell VJ. Acute barium poisoning with respiratory failure and rhabdomyolysis. Ann Emerg Med 1991;20:1138–1142.
74. Bowen CR, Topolov VY. Piezoelectric activity and sensitivity of novel composites based on barium titanate-hydroxyapatite composite ceramics. Adv Compos Mater Struct 2007;334-335:1113–1116.
75. Baxter FR, Turner IG, Bowen CR, Gittings JP, Chaudhuri JB. An in vitro study of electrically active hydroxyapatite-barium titanate ceramics using Saos-2 cells. J Mater Sci Mater Med 2009;20:1697–1708.
76. Zhang Y, Chen L, Zeng J, Zhou K, Zhang D. Aligned porous barium titanate/hydroxyapatite composites with high piezoelectric coefficients for bone tissue engineering. Mater Sci Eng C Mater Biol Appl 2014;39:143−149.
77. Tank KP, Chudasama KS, Thaker VS, Joshi MJ. Cobalt-doped nanohydroxyapatite: synthesis, characterization, antimicrobial and hemolytic studies. J Nanoparticle Res 2013;15:1–11.
78. Dollwet HHA, Sorenson JRJ. Historic Uses of Copper-Compounds in Medicine. Trace Elem Med 1985;2:80–87.
79. Tanizawa Y, Sawamura K, Suzuki T. Reaction characteristics of dental and synthetic apatites with Al3+ and La3+ ions in acidic solutions. J Chem Soc Faraday Trans 1990;86:4025–4029.
80. Owada H, Yamashita K, Umegaki T, Kanazawa T, Nagai M. Humidity-Sensitivity of Yttrium Substituted Apatite Ceramics. Solid State Ionics 1989;35:401–404.
81. Ergun C, Webster TJ, Bizios R, Doremus RH. Hydroxylapatite with substituted magnesium, zinc, cadmium, and yttrium. I. Structure and microstructure. J Biomed Mater Res 2002;59:305–311.
82. He X. Yttrium, Biological Effects. In: Kretsinger R, Uversky V, Permyakov E, editors. Encyclopedia of Metalloproteins. New York: Springer; 2013. p 2338–2340.
83. Magnusson G. The Behavior of Certain Lanthanons in Rats. Acta Pharmacol Toxicol (Copenh) 1963;20(SUPPL2):1-95.
84. Warrell RP Jr., Lovett D, Dilmanian FA, Schneider R, Heelan RT. Low-dose gallium nitrate for prevention of osteolysis in myeloma: Results of a pilot randomized study. J Clin Oncol 1993;11:2443–2450.
85. Melnikov P, Teixeira AR, Malzac A, Coelho MD. Gallium-containing hydroxyapatite for potential use in orthopedics. Mater Chem Phys 2009;117:86–90.
86. Gibson IR, Bonfield W. Novel synthesis and characterization of an AB-type carbonate-substituted hydroxyapatite. J Biomed Mater Res 2002;59:697–708.
87. Bigi A, Cojazzi G, Panzavolta S, Ripamonti A, Roveri N, Romanello M, Noris Suarez K, Moro L. Chemical and structural characterization of the mineral phase from cortical and trabecular bone. J Inorg Biochem 1997;68:45–51.
88. Montel G, Bonel G, Heughebaert JC, Trombe JC, Rey C. New concepts in the composition, crystallization and growth of the mineral component of calcified tissues. J Cryst Growth 1981;53:74–99.
89. Chiranjeevirao SV, Voegel JC, Frank RM. A Method of Preparation and Characterization of Carbonato-Apatites. Inorg Chim Acta-Bioinorg Chem 1983;78:43–46.
90. Barralet J, Best S, Bonfield W. Carbonate substitution in precipitated hydroxyapatite: An investigation into the effects of reaction temperature and bicarbonate ion concentration. J Biomed Mater Res 1998;41:79–86.
91. Landi E, Celotti G, Logroscino G, Tampieri A. Carbonated hydroxyapatite as bone substitute. J Eur Ceram Soc 2003;23:2931–2937.
92. Carlisle EM. Silicon: A possible factor in bone calcification. Science 1970;167:279–280.
93. Schwarz K, Milne DB. Growth-promoting effects of silicon in rats. Nature 1972;239:333–334.
94. Reffitt DM, Ogston N, Jugdaohsingh R, Cheung HF, Evans BA, Thompson RP, Powell JJ, Hampson GN. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone 2003;32:127–135.
95. Ruys AJ. Silicon-doped hydroxyapatite. J Aust Ceram Soc(Switzerland) 1993;29:71–80.
96. Baeza A, Izquierdo-Barba I, Vallet-Regí M. Biotinylation of silicon-doped hydroxyapatite: A new approach to protein fixation for bone tissue regeneration. Acta Biomater 2010;6:743–749.
97. Hahn B-D, Lee J-M, Park D-S, Choi J-J, Ryu J, Yoon W-H, Lee B-K, Shin D-S, Kim H-E. Aerosol deposition of silicon-substituted hydroxyapatite coatings for biomedical applications. Thin Solid Films 2010;518:2194–2199.
98. Li DH, Lin J, Lin DY, Wang XX. Synthesized silicon-substituted hydroxyapatite coating on titanium substrate by electrochemical deposition. J Mater Sci Mater Med 2011;22:1205–1211.
99. Rau JV, Cacciotti I, Laureti S, Fosca M, Varvaro G, Latini A. Bioactive, nanostructured Si-substituted hydroxyapatite coatings on titanium prepared by pulsed laser deposition. J Biomed Mater Res B Appl Biomater 2015;103:1621–1631.
100. Yang Y, Paital SR, Dahotre NB. Effects of SiO2 substitution on wettability of laser deposited Ca-P biocoating on Ti-6Al-4V. J Mater Sci Mater Med 2010;21:2511–2521.
101. Jenis LG, Banco RJ. Efficacy of silicate-substituted calcium phosphate ceramic in posterolateral instrumented lumbar fusion. Spine (Phila Pa 1976) 2010;35:1058–1063.
102. Lilja M, Lindahl C, Xia W, Engqvist H, Stromme M. The effect of Si-doping on the release of antibiotic from hydroxyapatite coatings. Journal of Biomaterials and Nanobiotechnology 2013;4:237–241.
103. Williams RL, Hadley MJ, Jiang PJ, Rowson NA, Mendes PM, Rappoport JZ, Grover LM. Thiol modification of silicon-substituted hydroxyapatite nanocrystals facilitates fluorescent labelling and visualisation of cellular internalisation. J Mater Chem B 2013;1:4370–4378.
104. Feito MJ, Lozano RM, Alcaide M, Ramírez-Santillán C, Arcos D, Vallet-Regí M, Portolés M-T. Immobilization and bioactivity evaluation of FGF-1 and FGF-2 on powdered silicon-doped hydroxyapatite and their scaffolds for bone tissue engineering. J Mater Sci: Mater Med 2011;22:405–416.
105. Cheng K, Shen G, Weng W, Han G, Ferreira JMF, Yang J. Synthesis of hydroxyapatite/fluoroapatite solid solution by a sol–gel method. Mater Lett 2001;51:37–41.
106. Cass RM, Croft JD, Jr., Perkins P, Nye W, Waterhouse C, Terry R. New bone formation in osteoporosis following treatment with sodium fluoride. Arch Intern Med 1966;118:111–116.
107. Farley JR, Wergedal JE, Baylink DJ. Fluoride directly stimulates proliferation and alkaline-phosphatase activity of bone-forming cells. Science 1983;222:330–332.
108. Chavassieux P, Boivin G, Serre CM, Meunier PJ. Fluoride increases rat osteoblast function and population after in vivo administration but not after in vitro exposure. Bone 1993;14:721–725.
109. Legeros RZ, Kijkowska R, Jia W, Legeros JP. Fluoride-Cation Interactions in the Formation and Stability of Apatites. J Fluor Chem 1988;41:53–64.
110. Bianco A, Cacciotti I, Lombardi M, Montanaro L, Bemporad E, Sebastiani M. F-substituted hydroxyapatite nanopowders: Thermal stability, sintering behaviour and mechanical properties. Ceram Int 2010;36:313–322.
111. Qu H, Wei M. The effect of fluoride contents in fluoridated hydroxyapatite on osteoblast behavior. Acta Biomater 2006;2(1):113–9.
112. Wang Y, Zhang S, Zeng X, Ma LL, Weng W, Yan W, Qian M. Osteoblastic cell response on fluoridated hydroxyapatite coatings. Acta Biomater 2007;3:191–197.
113. Kannan S, Rocha JHG, Ferreira JMF. Synthesis of hydroxy-chlorapatites solid solutions. Mater Lett 2006;60:864–868.
114. Schaller S, Henriksen K, Sorensen MG, Karsdal MA. The role of chloride channels in osteoclasts: ClC-7 as a target for osteoporosis treatment. Drug News Perspect 2005;18:489–495.
115. Garcia-Tunon E, Couceiro R, Franco J, Saiz E, Guitian F. Synthesis and characterisation of large chlorapatite single-crystals with controlled morphology and surface roughness. J Mater Sci Mater Med 2012;23:2471–2482.
116. Ekström TK. Synthetic and natural chlorine-bearing apatite. Contrib Miner Petrol 1973;38:329–338.
117. Kannan S, Rebelo A, Lemos AF, Barba A, Ferreira JMF. Synthesis and mechanical behaviour of chlorapatite and chlorapatite/β-TCP composites. J Eur Ceram Soc 2007;27:2287–2294.
118. Cacciotti I, Bianco A, Lombardi M, Montanaro L. Mg-substituted hydroxyapatite nanopowders: Synthesis, thermal stability and sintering behaviour. J Eur Ceram Soc 2009;29:2969–2978.
119. Paganias CG, Tsakotos GA, Koutsostathis SD, Macheras GA. Osseous integration in porous tantalum implants. Indian J Orthop 2012;46:505–513.
120. Miyaza T, Kim HM, Kokubo T, Ohtsuki C, Kato H, Nakamura T. Mechanism of bonelike apatite formation on bioactive tantalum metal in a simulated body fluid. Biomaterials 2002;23:827–832.
121. Vilarinho PM, Barroca N, Zlotnik S, Felix P, Fernandes MH. Are lithium niobate (LiNbO3) and lithium tantalate (LiTaO3) ferroelectrics bioactive? Mater Sci Eng C Mater Biol Appl 2014;39:395–402.
122. Tamai M, Isama K, Nakaoka R, Tsuchiya T. Synthesis of a novel beta-tricalcium phosphate/hydroxyapatite biphasic calcium phosphate containing niobium ions and evaluation of its osteogenic properties. J Artif Organs 2007;10:22–28.
123. da Rocha DN, de Andrade Gobbo L, da Silva MHP. Production and characterization of niobate apatite. J Mater Res Technol 2013;2:24–29.
124. Kuang Y, He X, Zhang Z, Li Y, Zhang H, Ma Y, Wu Z, Chai Z. Comparison study on the antibacterial activity of nano- or bulk-cerium oxide. J Nanosci Nanotechnol 2011;11:4103–4108.
125. Pelletier DA, Suresh AK, Holton GA, McKeown CK, Wang W, Gu B, Mortensen NP, Allison DP, Joy DC, Allison MR, et al. Effects of engineered cerium oxide nanoparticles on bacterial growth and viability. Appl Environ Microbiol 2010;76:7981–7989.
126. Feng Z, Liao Y, Ye M. Synthesis and structure of cerium-substituted hydroxyapatite. J Mater Sci: Mater Med 2005;16:417–421.
127. Lin YG, Yang ZR, Jiang C. Preparation, characterization and antibacterial property of cerium substituted hydroxyapatite nanoparticles. J Rare Earths 2007;25:452–456.
128. Ciobanu CS, Massuyeau F, Andronescu E, Stan MS, Dinischiotu A, Predoi D. Biocompatibility Study of Europium Doped Crystalline Hydroxyapatite Bioceramics. Dig J Nanomater Biostruct 2011;6:1639–1647.
129. Iconaru SL, Motelica-Heino M, Predoi D. Study on europium-doped hydroxyapatite nanoparticles by Fourier Transform Infrared Spectroscopy and their antimicrobial properties. J Spectros 2013; 2013.
130. Landi E, Uggeri J, Sprio S, Tampieri A, Guizzardi S. Human osteoblast behavior on as-synthesized SiO4 and B-CO3 co-substituted apatite. J Biomed Mater Res A 2010;94:59–70.
131. Kim SR, Lee JH, Kim YT, Riu DH, Jung SJ, Lee YJ, Chung SC, Kim YH. Synthesis of Si, Mg substituted hydroxyapatites and their sintering behaviors. Biomaterials 2003;24:1389–1398.
132. Zyman ZZ, Tkachenko MV. Sodium-carbonate co-substituted hydroxyapatite ceramics. Process Appl Ceram 2013;7:153–157.
133. Landi E, Sprio S, Sandri M, Celotti G, Tampieri A. Development of Sr and CO3 co-substituted hydroxyapatites for biomedical applications. Acta Biomater 2008;4:656–663.
134. Sprio S, Tampieri A, Landi E, Sandri M, Martorana S, Celotti G, Logroscino G. Physico-chemical properties and solubility behaviour of multi-substituted hydroxyapatite powders containing silicon. Mater Sci Eng C 2008;28:179–187.
135. Kay MI, Young RA, Posner AS. Crystal Structure of Hydroxyapatite. Nature 1964;204:1050–1052.
136. Matthew B, Steven JM, Andrew PB. Comparison of Hydrothermal and Sol-Gel Synthesis of Nano-Particulate Hydroxyapatite by Characterisation at the Bulk and Particle Level. Open J Inorg Non-Metal Mater 2012;2012.
137. Vijayalakshmi U, Rajeswari S. Preparation and characterization of microcrystalline hydroxyapatite using sol gel method. Trends Biomater Artif Organs 2006;19:57–62.
138. Meejoo S, Maneeprakorn W, Winotai P. Phase and thermal stability of nanocrystalline hydroxyapatite prepared via microwave heating. Thermochim Acta 2006;447:115–120.
139. Ramesh S, Tan CY, Aw KL, Yeo WH, Hamdi M, Sopyan I, Teng WD. Sintering behaviour of hydroxyapatite bioceramics. Med J Malays 2008;63:89–90.
140. El Feki H, Naddari T, Savariault JM, Ben Salah A. Localization of potassium in substituted lead hydroxyapatite: Pb9.30K0.60(PO4)6(OH)1.20 by X-ray diffraction. Solid State Sci 2000;2:725–733.
141. Rameshbabu N, Sampath Kumar TS, Prabhakar TG, Sastry VS, Murty KV, Prasad Rao K. Antibacterial nanosized silver substituted hydroxyapatite: synthesis and characterization. J Biomed Mater Res A 2007;80:581–591.
142. Riman RE, Suchanek W, Shuk P, Tenhuisen KS, Chen CW. For use as packing material/support for column chromatography, gas sensors and catalysts, as a host material for lasers, and as a plant growth substrate; biocompatable hard tissue implant. Google Patents; 2010.
143. Morrissey R, Rodriguez-Lorenzo LM, Gross KA. Influence of ferrous iron incorporation on the structure of hydroxyapatite. J Mater Sci Mater Med 2005;16:387–392.
144. Kikuchi M, Yamazaki A, Akao M, Aoki H. Cytotoxicity of synthetic barium hydroxyapatite. Biomed Mater Eng 1996;6:405–413.
145. Xiu Z, Lü M, Liu S, Zhou G, Su B, Zhang H. Barium hydroxyapatite nanoparticles synthesized by citric acid sol–gel combustion method. Mater Res Bull 2005;40:1617–1622.
146. Yasukawa A, Ueda E, Kandori K, Ishikawa T. Preparation and characterization of carbonated barium-calcium hydroxyapatite solid solutions. J Colloid Interface Sci 2005;288:468–474.
147. Mayer I, Layani JD, Givan A, Gaft M, Blanc P. La ions in precipitated hydroxyapatites. J Inorg Biochem 1999;73:221–226.
148. Nordström EG, Karlsson KH. Carbonate-doped hydroxyapatite. J Mater Sci: Mater Med 1990;1:182–184.
149. Zapanta LeGeros R. Apatites in biological systems. Prog Cryst Growth Characterization 1981;4:1–45.
150. Vallet-Regi M, Gonzalez-Calbet JM. Calcium phosphates as substitution of bone tissues. Prog Solid State Chem 2004;32:1–31.
151. Bianco A, Cacciotti I, Lombardi M, Montanaro L. Si-substituted hydroxyapatite nanopowders: synthesis, thermal stability and sinterability. Mater Res Bull 2009;44:345–354.
152. Chaikina MV, Pichugin VF, Surmeneva MA, Surmenev RA. Mechanochemical synthesis of hydroxyapatite with substitutions for depositing the coatings on medical implants by means of high fre quency magnetron sputtering. Chem Sustain Dev 2009;17:507–513.
153. Balamurugan A, Rebelo AHS, Lemos AF, Rocha JHG, Ventura JMG, Ferreira JMF. Suitability evaluation of sol–gel derived Si-substituted hydroxyapatite for dental and maxillofacial applications through in vitro osteoblasts response. Dental Mater 2008;24:1374–1380.
154. Darroudi M, Eshtiagh-Hosseini H, Housaindokht MR, Youssefi A. Preparation and Characterization of Fluorohydroxyapatite Nanopowders by Nonalkoxide Sol-Gel Method. Digest J Nanomater Biostruct 2010;5:29–33.
155. Jha LJ, Best SM, Knowles JC, Rehman I, Santos JD, Bonfield W. Preparation and characterization of fluoride-substituted apatites. J Mater Sci Mater Med 1997;8:185–191.
156. Maiti GC, Freund F. Incorporation of chlorine into hydroxy-apatite. J Inorg Nuclear Chem 1981;43:2633–2637.
157. Cho JS, Yoo DS, Chung YC, Rhee SH. Enhanced bioactivity and osteoconductivity of hydroxyapatite through chloride substitution. J Biomed Mater Res A 2014;102:455–469.
158. Caneva M, Botticelli D, Stellini E, Souza SLS, Salata LA, Lang NP. Magnesium-enriched hydroxyapatite at immediate implants: A histomorphometric study in dogs. Clin Oral Implants Res 2011;22:512–517.
159. de Lima IR, Alves GG, Soriano CA, Campaneli AP, Gasparoto TH, Ramos ES Jr., de Sena LA, Rossi AM, Granjeiro JM. Understanding the impact of divalent cation substitution on hydroxyapatite: an in vitro multiparametric study on biocompatibility. J Biomed Mater Res A 2011;98:351–358.
160. Bigi A, Bracci B, Cuisinier F, Elkaim R, Fini M, Mayer I, Mihailescu IN, Socol G, Sturba L, Torricelli P. Human osteoblast response to pulsed laser deposited calcium phosphate coatings. Biomaterials 2005;26:2381–2389.
161. Sima F, Socol G, Axente E, Mihailescu IN, Zdrentu L, Petrescu SM, Mayer I. Biocompatible and bioactive coatings of Mn2+-doped β-tricalcium phosphate synthesized by pulsed laser deposition. Appl Surf Sci 2007;254:1155–1159.
162. Ni GX, Chiu KY, Lu WW, Wang Y, Zhang YG, Hao LB, Li ZY, Lam WM, Lu SB, Luk KDK. Strontium-containing hydroxyapatite bioactive bone cement in revision hip arthroplasty. Biomaterials 2006;27:4348–4355.
163. Ni GX, Lu WW, Xu B, Chiu KY, Yang C, Li ZY, Lam WM, Luk KD. Interfacial behaviour of strontium-containing hydroxyapatite cement with cancellous and cortical bone. Biomaterials 2006;27:5127–5133.
164. Hou CH, Hou SM, Hsueh YS, Lin J, Wu HC, Lin FH. The in vivo performance of biomagnetic hydroxyapatite nanoparticles in cancer hyperthermia therapy. Biomaterials 2009;30:3956–3960.
165. Jianqing F, Huipin Y, Xingdong Z. Promotion of osteogenesis by a piezoelectric biological ceramic. Biomaterials 1997;18:1531–1534.
166. Ignjatovic N, Ajdukovic Z, Savic V, Najman S, Mihailovic D, Vasiljevic P, Stojanovic Z, Uskokovic V, Uskokovic D. Nanoparticles of cobalt-substituted hydroxyapatite in regeneration of mandibular osteoporotic bones. J Mater Sci Mater Med 2013;24:343–354.
167. Sato M, Sambito MA, Aslani A, Kalkhoran NM, Slamovich EB, Webster TJ. Increased osteoblast functions on undoped and yttrium-doped nanocrystalline hydroxyapatite coatings on titanium. Biomaterials 2006;27:2358–2369.
168. Redey SA, Nardin M, Bernache-Assolant D, Rey C, Delannoy P, Sedel L, Marie PJ. Behavior of human osteoblastic cells on stoichiometric hydroxyapatite and type A carbonate apatite: role of surface energy. J Biomed Mater Res 2000;50:353–364.
169. Thian ES, Huang J, Best SM, Barber ZH, Bonfield W. Silicon-substituted hydroxyapatite: The next generation of bioactive coatings. Mater Sci Eng C-Biomimetic Supramol Syst 2007;27:251–256.
170. Patel N, Best SM, Bonfield W, Gibson IR, Hing KA, Damien E, Revell PA. A comparative study on the in vivo behavior of hydroxyapatite and silicon substituted hydroxyapatite granules. J Mater Sci Mater Med 2002;13:1199–1206.
171. Hempel U, Reinstorf A, Poppe M, Fischer U, Gelinsky M, Pompe W, Wenzel KW. Proliferation and differentiation of osteoblasts on Biocement D modified with collagen type I and citric acid. J Biomed Mater Res B Appl Biomater 2004;71:130–143.